In addition, functionally-defined LSCs have been identified in populations from relapsed AML samples that contained all permutations of CD34 and CD38 expression, suggesting that LSCs are dynamic and unstable and can diverge and evolve with acquisition of different phenotypes at relapse [15]. This evidence concerns the gene CD34 and acute myeloid leukemia.